Description
SERVICE LINE ORIGINALLY REQUESTED 402 GLUCOSE TEST FOR THE PERIOD. MIS-CALCULATED AMOUNT NEEDED, MODIFIED ORDER TO INCREASE TO 1032 FOR PERIOD.
Base award description: ABBOTT PRECISION PXP GLUCOSE TESTING, CALIBRATION/VERIFICATION
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-09-30+$14,270= $14,270
- Mod 12010-02-12+$21,937= $36,206
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-09-30 | +$14,270 | $14,270 | ABBOTT PRECISION PXP GLUCOSE TESTING, CALIBRATION/VERIFICATION |
| Mod 1· CHANGE ORDER | 2010-02-12 | +$21,937 | $36,206 | SERVICE LINE ORIGINALLY REQUESTED 402 GLUCOSE TEST FOR THE PERIOD. MIS-CALCULATED AMOUNT NEEDED, MODIFIED ORD… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH3LDK8CFAK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N1004 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $187,594 | FY2026 |
| 36C24426N1005 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395,322 | FY2026 |
| 36C24426N1001 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,969 | FY2026 |
| 36C24426N1003 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $267,954 | FY2026 |
| 36C24426N1002 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $607,544 | FY2026 |
| 36C24426N1006 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $783,641 | FY2026 |
Other recipients under Q301 from 557-DUBLIN (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA557C15084 | IRIS INTERNATIONAL, INC. | 557-DUBLIN | $55,000 | FY2011 |
| V557C05033 | BECKMAN COULTER, INC | 557-DUBLIN | $144,000 | FY2010 |
| V557C05035 | ORTHO-CLINICAL DIAGNOSTICS INC | 557-DUBLIN | $600,000 | FY2010 |
| V557C05036 | TOSOH BIOSCIENCE, INC. | 557-DUBLIN | $16,800 | FY2010 |
| V557C05041 | ROCHE DIAGNOSTICS CORPORATION | 557-DUBLIN | $40,000 | FY2010 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_V557C05019_3600_V797P5478X_3600 · retrieved 2026-09-26.